ロード中...
Drug-induced reduction in estimated glomerular filtration rate in patients with ALK-positive non-small cell lung cancer treated with the ALK-inhibitor crizotinib
BACKGROUND: Renal side effects of crizotinib have not been investigated previously. METHODS: Estimated Glomerular Filtration Rate (eGFR) was calculated using the CKD-EPI creatinine-based prediction equation during the first 12 weeks of crizotinib and post-crizotinib prior to the introduction of any...
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3949169/ https://ncbi.nlm.nih.gov/pubmed/24258622 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.28478 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|